Overview

An Investigational Scan (68Ga-PSMA-11 PET/CT) for the Imaging of Prostate Cancer

Status:
Recruiting
Trial end date:
2027-07-01
Target enrollment:
Participant gender:
Summary
This trial studies how well 68Ga-PSMA-11 PET/CT scan works in imaging patients with prostate cancer. Diagnostic procedures, such as 68Ga-PSMA-11 PET/CT may find and diagnose prostate cancer and improve monitoring of treatment response.
Phase:
Phase 2
Details
Lead Sponsor:
University of Washington
Treatments:
Edetic Acid
Gallium 68 PSMA-11